
IRLAB Therapeutics AB
STO:IRLAB A

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is IRLAB A's stock price target?
Not Available
IRLAB A doesn't have any price targets made by Wall Street professionals.
What is IRLAB Therapeutics AB's Revenue forecast?
Projected CAGR
-25%
For the last 8 years the
compound annual growth rate for
IRLAB Therapeutics AB's revenue is
125%.
The projected
CAGR
for the next 2 years is
-25%.